High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 1, 2017, Pages 273-280

  Quan, Jingjing ^a   Zhao, Dongdong ^a   Liu, Lilin ^a   Chen, Yan ^a   Zhou, Jiancang ^a   Jiang, Yan ^a   Du, Xiaoxing ^a   Zhou, Zhihui ^a   Akova, Murat ^b   Yu, Yunsong ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOPERAZONE; CEFOPERAZONE PLUS SULBACTAM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FOSFOMYCIN; IMIPENEM; LATAMOXEF; LEVOFLOXACIN; MACROLIDE; MEROPENEM; METRONIDAZOLE; ORNIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TINIDAZOLE; VANCOMYCIN; VORICONAZOLE; BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHINA; CLINICAL FEATURE; COMMUNITY ACQUIRED INFECTION; EPIDEMIOLOGICAL DATA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENOTYPE; HEALTHCARE ASSOCIATED INFECTION; HEART FAILURE; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; TERTIARY CARE CENTER; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; YOUNG ADULT; ADOLESCENT; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MULTICENTER STUDY; RISK FACTOR; SECRETION (PROCESS); SEPSIS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED, 80 AND OVER; BETA-LACTAMASES; CHINA; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 85014570545     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw372     Document Type: Article

References (38)

1. Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 2014; 27: 647-64.
2. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-20.
3. Tumbarello M, Spanu T, Di Bidino R et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-blactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010; 54: 4085-91.
4. Rodriguez-Bano J, Picon E, Gijon P et al. Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010; 50: 40-8.
5. Kang CI, Song JH, Chung DR et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum b-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010; 36: 284-7.
6. Karfunkel D, Carmeli Y, Chmelnitsky I et al. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. Eur J Clin Microbiol Infect Dis 2013; 32: 513-21.
7. Sun Q, Tarnberg M, Zhao L et al. Varying high levels of faecal carriage of extended-spectrum β-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health. PLoS ONE 2014; 9: e113121.
8. Zhong YM, Liu WE, Liang XH et al. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China. J Antimicrob Chemother 2015; 70: 2223-7.
9. Zhang H, Zhou Y, Guo S et al. High prevalence and risk factors of fecal carriage of CTX-M type extended-spectrum β-lactamase-producing Enterobacteriaceae from healthy rural residents of Taian, China. Front Microbiol 2015; 6: 239.
10. Courpon-Claudinon A, Lefort A, Panhard X et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 2011; 17: 557-65.
11. Pitout JDD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
12. Zhou JC, Zheng SW, Yu YX et al. Trends in computed tomography utilization and association with hospital outcomes in a Chinese emergency department. PLoS ONE 2012; 7: e40403.
13. Doi Y, Park YS, Rivera JI et al. Community-associated extendedspectrum b-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 2013; 56: 641-8.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
15. Bae IK, Jang SJ, Kim J et al. Interspecies dissemination of the bla gene encoding PER-1 extended-spectrum β-lactamase. Antimicrob Agents Chemother 2011; 55: 1305-7.
16. Jones RN, Barry AL, Packer RR et al. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination. J Clin Microbiol 1987; 25: 1725-9.
17. Storberg V. ESBL-producing Enterobacteriaceae in Africa-a nonsystematic literature review of research published 2008-2012. Infect Ecol Epidemiol 2014; 4: doi:10.3402/iee.v4.20342.
18. Zhang J, Zheng B, Zhao L et al. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infect Dis 2014; 14: doi:10.1186/s12879-014-0659-0.
19. Kluytmans JA, Overdevest IT, Willemsen I et al. Extended-spectrum b-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 2013; 56: 478-87.
20. Xiao Y, Zhang J, Zheng B et al. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med 2013; 10: e1001556.
21. Yin X, Song F, Gong Yet al. A systematic review of antibiotic utilization in China. J Antimicrob Chemother 2013; 68: 2445-52.
22. Dong L, Yan H, Wang D. Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother 2008; 62: 410-5.
23. Alsan M, Schoemaker L, Eggleston K et al. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Lancet Infect Dis 2015; 15: 1203-10.
24. Currie J, LinW, Meng J. Addressing antibiotic abuse in China: an experimental audit study. J Dev Econ 2014; 110: 39-51.
25. CTX-M extendedspectrum b-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 2010; 16: 1475-81.
26. Ma J, Liu J-H, Lv L et al. Characterization of extended-spectrum b-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm. Appl Environ Microbiol 2012; 78: 3668-73.
27. Liu BT, Yang QE, Li L et al. Dissemination and characterization of plasmids carrying oqxAB-bla CTX-M genes in Escherichia coli isolates from food-producing animals. PLoS ONE 2013; 8: e73947.
28. Rao L, Lv L, Zeng Z et al. Increasing prevalence of extended-spectrum cephalosporin-resistant Escherichia coli in food animals and the diversity of CTX-M genotypes during 2003-2012. Vet Microbiol 2014; 172: 534-41.
29. Van Boeckel TP, Brower C, Gilbert M et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA 2015; 112: 5649-54.
30. Ben-Ami R, Rodriguez-Bano J, Arslan H et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49: 682-90.
31. Park SH, Choi SM, Lee DG et al. Emergence of extended-spectrum b-lactamase-producing Escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Microb Drug Resist 2011; 17: 537-44.
32. Jackson LA, Benson P, Neuzil KM et al. Burden of community-onset Escherichia coli bacteremia in seniors. J Infect Dis 2005; 191: 1523-9.
33. McKinnell JA, Miller LG, Eells SJ et al. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013; 34: 1077-86.
34. Rodriguez-Bano J, Alcala JC, Cisneros JM et al. Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Arch Intern Med 2008; 168: 1897-902.
35. Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum b-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089-94.
36. Yang L, Yang L, Lu DH et al. Co-prevalance of PMQR and 16S rRNA methylase genes in clinical Escherichia coli isolates with high diversity of CTX-M from diseased farmed pigeons. Vet Microbiol 2015; 178: 238-45.
37. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27: 543-74.
38. Rodriguez-Bano J, Navarro MD, Romero L et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006; 43: 1407-14.